155
Participants
Start Date
January 15, 2023
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Whole Brain Spectroscopy Imaging Array Mapping Layout
All study participants will receive whole brain spectroscopy imaging as a part of MRI study time points. Participants assigned to the advanced MR imaging array mapping layout study arm will receive tumor treating fields mapping from Optune that is created from the spectroscopy sequences or advanced MR imaging. Participants assigned to the conventional array mapping layout will still receive advanced imaging sequences or spectroscopy imaging at all time points.
RECRUITING
Abramson Cancer Center, Philadelphia
RECRUITING
Penn Medicine, University of Pennsylvania, Philadelphia
NovoCure Ltd.
INDUSTRY
National Institutes of Health (NIH)
NIH
National Cancer Institute (NCI)
NIH
Abramson Cancer Center at Penn Medicine
OTHER